Robert Hromas Selected Research

Robert Hromas Research Topics

Disease

37	Neoplasms (Cancer) 03/2024 - 10/2005
5	Genomic Instability 12/2022 - 01/2011
5	Leukemia 11/2021 - 08/2002
5	Genetic Translocation (Chromosomal Translocation) 01/2019 - 07/2010
4	Breast Neoplasms (Breast Cancer) 10/2023 - 01/2009
3	Infections 01/2021 - 12/2005
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 02/2012
2	Glioblastoma (Glioblastoma Multiforme) 12/2021 - 01/2019
2	Glioma (Gliomas) 12/2021 - 01/2019
2	Fanconi Anemia (Fanconi's Anemia) 12/2020 - 01/2019
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2005 - 10/2005
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023
1	Bone Resorption 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Crohn Disease (Crohn's Disease) 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Ulcerative Colitis 01/2021
1	Celiac Disease (Celiac Sprue) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Drug-Related Side Effects and Adverse Reactions 12/2019
1	Thrombocytopenia (Thrombopenia) 12/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Bone Marrow Failure Disorders 01/2019
1	Malignant Mesothelioma 10/2017
1	Carcinoma (Carcinomatosis) 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2015
1	Colonic Neoplasms (Colon Cancer) 07/2013
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 04/2013

Drug/Important Bio-Agent (IBA)

16	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2005
11	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2011
4	DT2216IBA 01/2023 - 12/2019
4	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2023 - 03/2014
3	snake venom protein C activatorIBA 03/2024 - 12/2019
3	Histones (Histone)IBA 10/2023 - 01/2011
3	Proteolysis Targeting ChimeraIBA 01/2022 - 01/2020
3	Antineoplastic Agents (Antineoplastics)IBA 12/2019 - 01/2011
2	UbiquitinIBA 10/2023 - 01/2022
2	Ligases (Synthetase)IBA 10/2023 - 01/2020
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2023 - 01/2022
2	Apoptosis Regulatory ProteinsIBA 01/2023 - 01/2023
2	navitoclaxIBA 12/2021 - 12/2019
2	Chemokine CCL21IBA 01/2021 - 08/2002
2	ChemokinesIBA 01/2021 - 08/2006
2	Poly (ADP-Ribose) Polymerase-1IBA 01/2019 - 05/2013
2	EndonucleasesIBA 11/2017 - 03/2014
2	A-Form DNA (A-DNA)IBA 05/2013 - 06/2011
2	TransposasesIBA 07/2010 - 05/2010
2	trioctyl phosphine oxide (TOPO)IBA 01/2009 - 10/2008
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 01/2023
1	Bcl-2-Like Protein 11IBA 01/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2023
1	Mitogen-Activated Protein KinasesIBA 01/2023
1	butyl phosphorotrithioate (DEF)IBA 12/2022
1	olaparibIBA 01/2022
1	carbazoleIBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	Annexin A5IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Gemcitabine FDA Link 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	talazoparibIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	RNA Demethylase AlkB Homolog 5IBA 01/2022
1	6-methyladenineIBA 01/2022
1	CrizotinibIBA 12/2021
1	Neutralizing AntibodiesIBA 12/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Fanconi Anemia Complementation Group D2 ProteinIBA 12/2020
1	Discoidin Domain ReceptorsIBA 06/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	IonsIBA 01/2019
1	Protons (Proton)IBA 01/2019
1	Proto-Oncogene Proteins c-metIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	CarbonIBA 01/2019
1	Complementary DNA (cDNA)IBA 11/2017
1	Adenosine (Adenocard)FDA LinkGeneric 01/2016
1	RibonucleotidesIBA 01/2016
1	AICA ribonucleotide (ZMP)IBA 01/2016
1	Phosphates (Orthophosphate)IBA 01/2016
1	NSC666715IBA 01/2015
1	Temozolomide (Temodar)FDA LinkGeneric 01/2015
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2015
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 03/2014
1	SmokeIBA 04/2013
1	QuinolonesIBA 12/2012
1	Ciprofloxacin (Cipro)FDA LinkGeneric 12/2012
1	PlatinumIBA 02/2012

Therapy/Procedure

15	Therapeutics 03/2024 - 08/2002
9	Drug Therapy (Chemotherapy) 01/2022 - 10/2005
5	Radiotherapy 01/2023 - 10/2017
2	Aftercare (After-Treatment) 01/2023 - 12/2005
1	Transplantation 01/2023
1	Immunotherapy 01/2022